Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2006 Nov;22(13):1113-6.
doi: 10.1016/s0828-282x(06)70946-1.

Endothelial progenitor cell-seeded grafts: rash and risky

Affiliations
Review

Endothelial progenitor cell-seeded grafts: rash and risky

Joris I Rotmans et al. Can J Cardiol. 2006 Nov.

Abstract

The patency of prosthetic vascular grafts is impaired by intimal hyperplasia (IH) near the anastomotic regions. The absence of a functional endothelial monolayer on the prosthetic grafts is an important stimulus for IH. To improve the outcome of synthetic vascular bypass surgery, cell seeding is a promising concept that has been extensively investigated and is still evolving. In the present paper, the concept of prosthetic graft cell seeding is discussed, with emphasis on its newest era: seeding with endothelial progenitor cells. Although experimental studies on prosthetic graft seeding using endothelial progenitor cells have shown excellent results on graft endothelialization, none of these studies reported favourable effects on the more clinically relevant end points such as IH or graft patency.

La perméabilité des greffes vasculaires prosthétiques est perturbée par l’hyperplasie intimale (HI) près des zones anastomosées. L’absence de monocouche endothéliale fonctionnelle sur les greffes prosthétiques est un important stimulus d’HI. Pour améliorer l’issue des pontages vasculaires synthétiques, l’implantation de cellules est un concept prometteur qui a fait l’objet de recherches poussées et qui est toujours en évolution. Dans le présent article, le concept d’implantation de greffes de cellules prosthétiques est abordé, surtout axé sur son domaine le plus novateur : l’implantation de cellules souches endothéliales. Bien que les études expérimentales sur l’implantation de cellules prosthétiques au moyen de cellules souches endothéliales aient obtenu d’excellents résultats sur l’endothélialisation des greffes, aucune n’a d’effets favorables sur les éléments décisifs plus pertinents d’un point de vue clinique, comme l’HI et la perméabilité.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Potential mechanisms of protective effects of seeded endothelial cells (ECs) on intimal hyperplasia in vascular prosthesis. First, the production of nitric oxide (NO), C-type natriuretic peptide (CNP) and heparan sulphate (HS) by ECs leads to inhibiton of profileration and migration of vascular smooth muscle cells (VSMCs). Second, the production of NO and prostacyclin (PGI2) by ECs inhibits platelet aggregation, with subsequent reduction in release of platelet-derived growth factor (PDGF) and thromboxane A2 (TxA2) by platelets. Third, the mechanical barrier formed by ECs prevents infiltration of leukocytes, thereby reducing the production of growth-stimulation cytokines including tumour necrosis factor-alpha (TNF-α) and transforming growth factor-beta (TGF-β). + Stimulatory effect;− Inhibitory effect
Figure 2
Figure 2
Representative sections obtained at four weeks after arteri-ovenous graft implantation in pigs. Enhanced endothelialization in the anti-CD34-coated grafts coincided with profound increase in intimal hyperplasia at the venous anastomosis. Lectin-stained sections of bare (A) and CD34-coated grafts (B) obtained from the centre of the graft. Lectin is a marker for endothelial cells. Elastin von Gieson-stained sections of the venous anastomosis of bare grafts (C) and CD34-coated grafts (D). Reproduced from reference with permission

Comment in

Similar articles

Cited by

References

    1. Cines DB, Pollak ES, Buck CA, et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood. 1998;91:3527–61. - PubMed
    1. Klinkert P, Post PN, Breslau PJ, van Bockel JH. Saphenous vein versus PTFE for above-knee femoropopliteal bypass. A review of the literature. Eur J Vasc Endovasc Surg. 2004;27:357–62. - PubMed
    1. Schwab SJ, Harrington JT, Singh A, et al. Vascular access for hemodialysis. Kidney Int. 1999;55:2078–90. - PubMed
    1. USRDS 2002. Annual Data Report: Atlas of End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; Bethesda, MD: 2002.
    1. Rotmans JI, Pasterkamp G, Verhagen HJ, Pattynama PM, Blankestijn PJ, Stroes ES. Hemodialysis access graft failure: Time to revisit an unmet clinical need? J Nephrol. 2005;18:9–20. - PubMed

MeSH terms

Substances

LinkOut - more resources